Effect of long-term treatment of L-ornithine on visual function and retinal histology in the rats

Biological & Pharmaceutical Bulletin
Kenji SakamotoKunio Ishii

Abstract

L-Ornithine is a non-proteinogenic amino acid, abundant in freshwater clams and commercially available as an oral nutritional supplement. L-Ornithine is metabolized by ornithine-δ-aminotransferase. Deficiency of this enzyme causes gyrate atrophy of the choroid and retina, an autosomal recessive hereditary disease characterized by the triad of progressive chorioretinal degeneration, early cataract formation, and type II muscle fiber atrophy, with hyperornithinemia. However, it is unknown whether long-term L-ornithine supplementation affects visual function and retinal histology. The aim of the present study is to determine the effect of long-term supplementation of excess amounts of L-ornithine on visual function and retinal histology in rats. Male Brown Norway rats at six weeks of age were allowed free access to chow containing 4% (w/w) L-ornithine (the high ornithine diet) or that containing 4% (w/w) casein (the control diet) for 49 weeks. The dose of L-ornithine calculated from the food intake was approximately 0.8 g/d/animal, which was 100 times higher than the recommended dose for healthy humans. The amplitude of the a-wave of the scotopic rod-cone electroretinogram and the number of cells in the ganglion cell layer in the ...Continue Reading

References

Feb 1, 1989·American Journal of Medical Genetics·B ChadefauxP Kamoun
Apr 1, 1981·Ophthalmology·T KuwabaraM I Kaiser-Kupfer
Oct 1, 1995·Experimental Animals·I KiyosawaK W Takahashi
Sep 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·H C HaR A Casero
Feb 3, 2000·Proceedings of the National Academy of Sciences of the United States of America·T WangD Valle
Dec 20, 2000·American Journal of Physiology. Endocrinology and Metabolism·H LiG Wu
Mar 21, 2002·Journal of Agricultural and Food Chemistry·Allison F WrenLeslie Norris
Aug 15, 2002·The Journal of Surgical Research·Han Ping ShiAdrian Barbul
Jun 19, 2004·International Journal of Toxicology·Shoji TsubukuTakeshi Kimura
Jun 19, 2004·International Journal of Toxicology·Shoji TsubukuTakeshi Kimura
Mar 8, 2005·The Tohoku Journal of Experimental Medicine·Yumiko OhkuboHajime Togari
Jun 15, 2007·Journal of Medical Case Reports·Alireza Javadzadeh, Davood Gharabaghi
Jul 25, 2007·Clinical and Experimental Pharmacology & Physiology·William DuranteRobert A Johnson
Apr 15, 2008·Biochimica Et Biophysica Acta·Ferdinando Palmieri
Oct 14, 2008·Human Molecular Genetics·Kenji SakamotoPatsy M Nishina
Mar 4, 2010·Journal of Pharmacological Sciences·Kenji SakamotoKunio Ishii
Mar 23, 2010·European Journal of Pharmacology·Kenji SakamotoKunio Ishii
Jul 1, 2011·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Kenji SakamotoKunio Ishii
Jul 20, 2011·The British Journal of Nutrition·Seiji HayasakaAkihiro Ohira
Apr 23, 2013·Clinical & Experimental Ophthalmology·Hassan I H El-SayyadEzaldin A M Mohammed

❮ Previous
Next ❯

Citations

Jul 3, 2015·Biological & Pharmaceutical Bulletin·Yousuke ShiraiKunio Ishii
Oct 30, 2016·European Journal of Pharmacology·Kenji SakamotoKunio Ishii

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.